Literature DB >> 19915835

Impaired myocardial blood flow reserve in subjects with metabolic syndrome analyzed using positron emission tomography and N-13 labeled ammonia.

Hiroki Teragawa1, Koichi Morita, Hiroki Shishido, Nobuaki Otsuka, Yutaka Hirokawa, Kazuaki Chayama, Nagara Tamaki, Yasuki Kihara.   

Abstract

PURPOSE: Coronary vasomotor response might be impaired in metabolic syndrome (MS); however, the precise abnormality has not been elucidated. The aim of this study was to assess coronary-vasomotor response in MS subjects using N-13 labeled ammonia and positron emission tomography. METHODS AND
RESULTS: Myocardial blood flow (MBF) was measured at rest and during adenosine infusion in MS subjects (n = 13, MS group) with no definite evidence of heart disease and in subjects without MS (n = 14, non-MS group). Coronary vascular resistance (CVR) was calculated by dividing the mean aortic blood pressure by MBF. Myocardial blood flow reserve (MFR) was calculated as the ratio of the MBF during adenosine infusion to that during rest. Blood chemical parameters were measured to evaluate their relationship with MFR. During adenosine infusion, MBF was lower (p = 0.0085) and CVR higher (p = 0.0128) in the MS group than in the non-MS group and MFR was significantly lower in the MS group than in the non-MS group (2.13 +/- 0.99 vs. 3.38 +/- 0.95, p = 0.0027). Multivariate analysis demonstrated that the homeostasis model assessment-insulin resistance (p < 0.05) and the presence of hypertension (p < 0.05) were independent determinants of MFR.
CONCLUSIONS: The results indicate that MFR was impaired in MS subjects, suggesting that an abnormal coronary microvascular response occurred in these subjects. This abnormality may have been partially due to insulin resistance and hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19915835     DOI: 10.1007/s00259-009-1307-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  39 in total

1.  Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography.

Authors:  M Kozàkovà; C Palombo; L Pratali; G Pittella; F Galetta; A L'Abbate
Journal:  Hypertension       Date:  1997-02       Impact factor: 10.190

2.  Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging.

Authors:  G D Hutchins; M Schwaiger; K C Rosenspire; J Krivokapich; H Schelbert; D E Kuhl
Journal:  J Am Coll Cardiol       Date:  1990-04       Impact factor: 24.094

3.  Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function.

Authors:  Y Higashi; S Sasaki; K Nakagawa; H Matsuura; G Kajiyama; T Oshima
Journal:  J Am Coll Cardiol       Date:  2001-03-01       Impact factor: 24.094

4.  Hyperglycemia rather than insulin resistance is related to reduced coronary flow reserve in NIDDM.

Authors:  I Yokoyama; T Ohtake; S Momomura; K Yonekura; S Woo-Soo; J Nishikawa; Y Sasaki; M Omata
Journal:  Diabetes       Date:  1998-01       Impact factor: 9.461

5.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

Authors:  H O Steinberg; H Chaker; R Leaming; A Johnson; G Brechtel; A D Baron
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

6.  Endothelial function and oxidative stress in renovascular hypertension.

Authors:  Yukihito Higashi; Shota Sasaki; Keigo Nakagawa; Hideo Matsuura; Tetsuya Oshima; Kazuaki Chayama
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

7.  Adiponectin stimulates production of nitric oxide in vascular endothelial cells.

Authors:  Hui Chen; Monica Montagnani; Tohru Funahashi; Iichiro Shimomura; Michael J Quon
Journal:  J Biol Chem       Date:  2003-08-27       Impact factor: 5.157

8.  Coronary vasomotor abnormalities in insulin-resistant individuals.

Authors:  Manuel J Quiñones; Miguel Hernandez-Pampaloni; Heinrich Schelbert; Isabel Bulnes-Enriquez; Xochitl Jimenez; Gustavo Hernandez; Roxana De La Rosa; Yun Chon; Huiying Yang; Susanne B Nicholas; Tamara Modilevsky; Katherine Yu; Katja Van Herle; Lawrence W Castellani; Robert Elashoff; Willa A Hsueh
Journal:  Ann Intern Med       Date:  2004-05-04       Impact factor: 25.391

9.  Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.

Authors:  Gang Hu; Qing Qiao; Jaakko Tuomilehto; Beverley Balkau; Knut Borch-Johnsen; Kalevi Pyorala
Journal:  Arch Intern Med       Date:  2004-05-24

10.  Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients.

Authors:  Masanao Naya; Takahiro Tsukamoto; Koichi Morita; Chietsugu Katoh; Tomoo Furumoto; Satoshi Fujii; Nagara Tamaki; Hiroyuki Tsutsui
Journal:  J Am Coll Cardiol       Date:  2007-09-04       Impact factor: 24.094

View more
  5 in total

Review 1.  Heart of the matter: coronary dysfunction in metabolic syndrome.

Authors:  Zachary C Berwick; Gregory M Dick; Johnathan D Tune
Journal:  J Mol Cell Cardiol       Date:  2011-07-13       Impact factor: 5.000

Review 2.  Cardiovascular consequences of metabolic syndrome.

Authors:  Johnathan D Tune; Adam G Goodwill; Daniel J Sassoon; Kieren J Mather
Journal:  Transl Res       Date:  2017-01-09       Impact factor: 7.012

3.  Contribution of voltage-dependent K⁺ channels to metabolic control of coronary blood flow.

Authors:  Zachary C Berwick; Gregory M Dick; Steven P Moberly; Meredith C Kohr; Michael Sturek; Johnathan D Tune
Journal:  J Mol Cell Cardiol       Date:  2011-07-12       Impact factor: 5.000

Review 4.  Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis.

Authors:  Joanna M Bilak; Uazman Alam; Christopher A Miller; Gerry P McCann; Jayanth R Arnold; Prathap Kanagala
Journal:  Card Fail Rev       Date:  2022-07-01

5.  De Novo Glutamine Synthesis: Importance for the Proliferation of Glioma Cells and Potentials for Its Detection With 13N-Ammonia.

Authors:  Qiao He; Xinchong Shi; Linqi Zhang; Chang Yi; Xuezhen Zhang; Xiangsong Zhang
Journal:  Mol Imaging       Date:  2016-04-26       Impact factor: 4.488

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.